Actively Recruiting
Emergency PWAS in Respiratory Infectious Disease
Led by The University of Hong Kong · Updated on 2026-05-12
2000
Participants Needed
1
Research Sites
263 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Develop an emergency PanorOmics Wide Association Study (ePWAS) for the early, rapid biological and pathophysiological characterisation of known and novel Infectious Diseases in adult patients presenting to emergency departments with suspected, acute, community-acquired respiratory infectious disease (scaRID). Phase 1 1. Develop an ED-ID biobank (named ePWAS-RID). Phase 2 2. Targeted research for the discovery of novel diagnostics, prognostics and therapeutics
CONDITIONS
Official Title
Emergency PWAS in Respiratory Infectious Disease
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults 18 years of age or older
- Suspected, acute, community-acquired respiratory infectious disease (scaRID)
- Onset of symptoms less than 8 days prior to enrollment
- Presence of fever or chills or temperature above 37.5°C or hypothermia or abnormal white blood cell count or new altered mental status
- At least one respiratory symptom such as new cough, sputum production, chest pain, dyspnea, tachypnea, abnormal lung exam, respiratory failure, or systemic/gastrointestinal symptoms judged by physician
- Ability to provide informed consent
You will not qualify if you...
- Refusal to provide consent
- Hospitalization within the previous 28 days
- Currently enrolled in another clinical trial
- Presence of cellulitis, skin or orthopedic infections
- Urinary tract infection
- Acute abdominal sepsis
- Sexually transmitted disease
- HIV infection
- Immunocompromised status or potential neutropenic fever
- Solid organ or stem-cell transplant within past 90 days
- Active graft-versus-host disease or bronchiolitis obliterans
- Severe travel-related diseases requiring urgent hospital care such as malaria, dengue, typhoid, or rickettsial diseases
- Stroke
- Toxidrome
- Non-organic acute psychosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Hong Kong University
Hong Kong, China
Actively Recruiting
Research Team
T
Timothy H Rainer, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
7
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here